Endra Life Sciences
(NASDAQ) NDRA
Endra Life Sciences Financials at a Glance
Market Cap
$6.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$7.30M
EPS (TTM)
-$8.15
P/E Ratio
-0.59
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$5.00
Volume
1,220
Open
$5.00
Price
$5.00
Volume
1,220
Open
$5.00
Previous Close
$5.00
Daily Range
$5.00 - $5.00
52-Week Range
$2.96 - $11.96
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$5.00
Volume
1,220
Open
$5.00
Previous Close
$5.00
Daily Range
$5.00 - $5.00
52-Week Range
$2.96 - $11.96
Estimated Earnings Date
Aug 13, 2026
NDRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Endra Life Sciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11
CEO
Alexander Y. Tokman
Website
www.endrainc.comHeadquarters
Ann Arbor, MI 48105-1570, US
NDRA Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-513.22%
Return on Capital
-209.38%
Return on Assets
-212.39%
Earnings Yield
-1.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.27M
Volume
1.22K
Avg. Volume
28.58K
Financials (TTM)
Gross Profit
-$39.72K
Operating Income
-$6.47M
EBITDA
-$7.15M
Operating Cash Flow
-$5.01M
Capital Expenditure
-$3.00M
Free Cash Flow
-$8.01M
Cash & ST Invst.
$356.46K
Total Debt
$461.21K
Endra Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$39.72K
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$289.70K
N/A
Employees
21
N/A
Net Income
-$1.31M
-26.5%
EBITDA
-$1.27M
-28.4%
Quarterly Fundamentals
Total Cash
$356.46K
-82.7%
Total Debt
$461.21K
-21.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$327.25K
-29.0%
Short Term Debt
$133.95K
+6.2%
Return on Assets
-2.12%
N/A
Return on Invested Capital
-2.48%
N/A
Free Cash Flow
-$1.12M
+14.6%
Operating Cash Flow
-$1.12M
+13.4%